Hey readers! 👋
Welcome back to another packed week in the T1D world. This week we've got a fascinating mix: from Stanford scientists reprogramming immune systems in mice, to a new gene therapy trial heading to humans, to research confirming what many of us already suspected - that emotional distress in teens with T1D isn't "just feelings," it directly impacts blood sugar. Plus, some exciting tech updates and a reminder that moving your body does more than you think. Let's dive in! 🧬
🔬 Research Frontiers
Scientists create blended immune system to reverse T1D in mice - Stanford researchers demonstrated that transplanting donor bone marrow stem cells alongside islet cells can reprogram the immune system to accept insulin-producing cells, all without lifelong immunosuppression. – Live Science
The approach, called mixed chimerism, uses a gentler conditioning protocol combining specific antibodies, low-dose radiation, and the existing drug baricitinib. Mice maintained normal blood glucose for at least 20 weeks. As researcher Judith Shizuru put it:
"The graft sticks and stays."
It's still early days, and translating this to humans means overcoming donor matching, antibody availability, and decades-long immune balance challenges. But the concept of teaching the immune system tolerance rather than suppressing it entirely is a compelling direction.
First-ever gene therapy trial for T1D set to launch - The PROGRESS study will test KRIYA-839, a one-time intramuscular injection that delivers glucokinase and insulin genes directly into muscle tissue, aiming for durable glucose control without immunosuppression. – Medscape
Preclinical data in mice and dogs has shown up to four years of safety and glucose-normalizing effects. Importantly, this isn't gene editing - the therapy doesn't alter chromosomes. It's a notable step toward what researchers are calling a potential "functional" approach to long-term T1D management.
Beta cell-targeted PD-1 agonist protects islets from immune attack - A new bispecific molecule called ImmTAAI was shown to protect beta cells from T-cell killing in live human pancreas slices by delivering a targeted "stand down" signal to autoreactive immune cells. – PubMed
"These data demonstrate that ImmTAAI molecules have the potential to limit T cell activity locally, making this an attractive platform to elicit targeted immunoregulation in T1D."
The idea of locally calming the immune response right at the pancreas, rather than broadly suppressing it, is a smart strategy worth watching.
Oxygen-generating implant keeps insulin cells alive long-term - Cornell engineers built a device that solves one of cell therapy's biggest problems: implanted cells dying from oxygen starvation. Their electrochemical oxygen generator paired with an immune-protective capsule maintained tight glucose control in rats. – Cornell Chronicle
AAT-overexpressing stem cells reverse new-onset diabetes in over 50% of mice by boosting regulatory T cells and suppressing autoimmune attack. – Elsevier Inc
🧠 Mental Health & Quality of Life
Diabetes distress directly linked to higher blood sugar in teens - A three-year study of 172 adolescents found that emotional distress undermines self-management behaviors like glucose monitoring and insulin dosing, which in turn raises HbA1c. – University of Miami
"The big message from this study is that diabetes distress is very common and it's a very meaningful factor to consider for the health care teams that are taking care of these kids."
What stands out here is that teen self-reports of their own management were more reliable predictors than caregiver reports. This underscores the importance of listening directly to adolescents and integrating psychological screening into routine clinic visits. If your teen's numbers are climbing, the answer might not be more insulin education - it might be emotional support first.
Study of 141 adolescents in India found nearly 59% had impaired diabetes-specific quality of life, with age and glycemic control as key predictors. – Bhageerathy et al.
⚙️ Tech & Tools
Summer 2025 diabetes tech roundup from ADA Scientific Sessions - A comprehensive overview covering AI tools like GlyTwin for early T1D detection, new patch-style pumps from Medtronic and Beta Bionics, cell therapies from Vertex and Sana, and next-gen sensors from Biolinq and Glucotrack. – Beyond Type 1
Sequel Med Tech's twiist AID system - Built on the Loop algorithm, twiist uses sound-wave technology to measure exact insulin volume at every dose, detecting blockages up to nine times faster than other pumps and reducing severe lows by up to 90%. – GlobeNewswire
Beta Bionics launches Bionic Insights, a new analytics feature for the iLet pump that categorizes patient data into "Areas of Success" and "Areas of Opportunity" for more productive clinic conversations. – Drug Delivery Business
Dexcom G6 and G7 accuracy confirmed in hospitalized pediatric patients, with G7 outperforming G6 (MARD 9.8% vs. 11.2%). – Diabetes Technology & Therapeutics
New study on designing carb-counting apps for young adults emphasizes personalization and user control over automation in insulin dosing decisions. – Journal of Medical Internet Research
Fully automated bihormonal closed-loop system using ultra-rapid insulin shows promise for hands-free glucose management. – PubMed
🏃 Exercise & Glucose Predictability
Physical activity improves glucose predictability in T1D - Data from the largest T1D exercise trial found that people with higher weekly physical activity had more predictable glucose patterns, which also improved the accuracy of AI forecasting models. – PubMed
"Regular exercise not only promotes better glycemic regulation but also improves the performance of predictive models."
This is a practical takeaway: consistent movement doesn't just help your numbers today, it makes your glucose behavior easier to predict tomorrow. That's good news for anyone relying on automated insulin delivery.
🎙️ Worth a Listen
Juicebox Podcast: Family Ties (Parts 1 & 2) - Siblings Crystal and Jason share their multigenerational experience with T1D, from growing up with a father who had the disease to how a toddler's diagnosis transformed their entire family's approach to management. – Juicebox Podcast
That's a wrap for this week! As always, we love hearing from you - hit reply with questions, comments, or anything on your mind. 💬
Made with ❤️ by Data Drift Press